Form 4: CEO Simeon Kohl's PHLT Stock Transactions

Performant Healthcare CEO Simeon Kohl reported the acquisition of common stock through RSU vesting and the sale of shares to cover tax liabilities.

Summary

• Simeon Kohl, Chief Executive Officer and Director of Performant Healthcare Inc. (PHLT), reported transactions on August 11, 2025.
• Acquired a total of 81,014 shares of common stock (41,538 shares from one RSU grant and 39,476 shares from another) through the vesting of Restricted Stock Units (RSUs) at an exercise price of $0.00 per share.
• Disposed of a total of 31,637 shares of common stock (16,221 shares and 15,416 shares) at a price of $7.63 per share to cover tax liabilities associated with the RSU vesting.
• Following these transactions, Simeon Kohl directly beneficially owns 519,304 shares of Performant Healthcare Inc. common stock.
• He also holds 159,957 unvested Restricted Stock Units (41,538 from the August 8, 2022 grant and 118,419 from the August 5, 2024 grant).

Sentiment

Score: 7

Explanation: The filing indicates a routine, positive event for the executive (vesting of compensation) and an increase in direct beneficial ownership, aligning executive interests with shareholders. The sale for taxes is standard and not negative.

Positives

• CEO Simeon Kohl increased his direct beneficial ownership of common stock by a net of 49,377 shares (81,014 acquired 31,637 disposed for taxes).
• The acquisition of shares through RSU vesting indicates continued long-term incentive alignment between management and shareholders.

Negatives

• A portion of the vested shares were sold to cover tax liabilities, which is a common practice but reduces the immediate increase in direct ownership.

Future Outlook

The filing indicates future vesting events for Simeon Kohl's remaining Restricted Stock Units, which are scheduled to vest in equal installments on the anniversaries of their grant dates (August 8, 2022, and August 5, 2024), provided continuous service.

Industry Context

This Form 4 filing is a routine insider transaction report and does not provide broader industry context or trends. It reflects standard executive compensation practices involving Restricted Stock Units.

Comparison to Industry Standards

• This filing details standard executive compensation practices involving Restricted Stock Units (RSUs) and their vesting, which is common across publicly traded companies.
• The sale of shares to cover tax liabilities upon RSU vesting is also a standard practice.
• No specific comparable companies or projects are mentioned in this transactional filing.

Stakeholder Impact

• Shareholders: Increased alignment of CEO's interests with shareholders due to increased direct stock ownership.
• Employees: No direct impact on general employees, but reflects executive compensation structure.

Next Steps

• Future vesting events for Simeon Kohl's remaining Restricted Stock Units are expected on the anniversaries of their grant dates (August 8, 2022, and August 5, 2024), contingent on continuous service.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation (RSU vesting and tax-related sales). While it shows an increase in the CEO's direct beneficial ownership, it does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. It primarily confirms the ongoing alignment of executive incentives with shareholder value.

Keywords

Performant Healthcare, PHLT, Simeon Kohl, Insider Trading, Form 4, Restricted Stock Units, RSU Vesting, Executive Compensation, CEO Stock